Loading...
Home 2018-06-06T17:51:37+00:00

Oncobiologics…

…is a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex monoclonal antibody (mAb) therapeutics.

BioSymphony Platform Icon

BioSymphony Platform

By leveraging our proprietary BioSymphony™ Platform, Oncobiologics is able to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.

Biosimilars Icon

BIOSIMILARS

We cost-effectively develop biosimilars candidates on an accelerated timeline

Innovative mAb Therapeutics Icon

NOVEL THERAPEUTICS

Our strategy includes developing innovative mAb candidates

CDMO Services Icon

CDMO

We leverage our platform to provide development and manufacturing for development stage biotechnology firms